SS Innovations Demonstrates Long-Distance Telesurgery Capabilities at Royal Australian College of Surgeons Annual Scientific Congress
Landmark telesurgery performed in Perth, Australia, more than 4,500 miles from the patient in India, utilizing the SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console FORT LAUDERDALE, Fla., May 07, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – SS Innovations International, Inc.
SS Innovations Unveils Cutting-Edge Surgical Robotic Technologies at SMRSC 2026
Innovations under development by Company include the SSi Vimana Aero, SSi Avtara and SSi Operion Fort Lauderdale, FL, April 23, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – SS Innovations International, Inc.
SS Innovations to Host SMRSC 2026 in New Delhi, India from April 9-11, 2026
Conference to Unite Global Leaders at the Forefront of Surgical Robotic Innovation FORT LAUDERDALE, Fla., April 07, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – SS Innovations International, Inc.
SS Innovations' SSi Mantra Surgical Robotic System Approved for Telesurgeries in Indonesia and the Philippines
Company surpasses milestone of 150 cumulative telesurgeries successfully performed with the SSi Mantra Fort Lauderdale, FL, March 18, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – SS Innovations International, Inc.
SS Innovations Reports Fourth Quarter and Full Year 2025 Financial Results
Strong growth in SSi Mantra installations, procedures and revenues Fort Lauderdale, FL, March 10, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – SS Innovations International, Inc.
SS Innovations Announces Completion of an $18.6 Million Private Placement to Support Growth Initiatives
Financing led by Certain of the Company's Directors and Executive Officers Fort Lauderdale, FL, March 9, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – SS Innovations International, Inc.
SS Innovations Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2025
Anticipated strong revenue growth driven by higher unit sales of SSi Mantra surgical robotic system Fort Lauderdale, FL, January 13, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – SS Innovations International, Inc.
SS Innovations Develops New Instruments to Advance Robotic Surgery in Large, Underserved Patient Segments, including Pediatric and Cardiac Markets
Smaller 5-millimeter instruments to be incorporated into the SSi Mantra surgical robotic system Takeways: Fort Lauderdale, FL, January 6, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – SS Innovations International, Inc.
SS Innovations Submits 510(k) Premarket Notification to the FDA for the Company's SSi Mantra Surgical Robotic System
— Submission covers multiple indications including general, urological, colorectal, gynecological and cardiac surgeries — SS Innovations has officially submitted a 510(k) application to the U.S. FDA for its SSi Mantra surgical robotic system, aiming for clearance to enter the U.S. market.
SS Innovations Announces Successful Completion of First Telesurgery Performed with the Company's SSi Mantra Tele Surgeon Console
Compact New Console Facilitates Performance of Telesurgeries from a Wide Range of Locations, including Physicians' Offices Key Takeaways Historic First for Robotic TelesurgerySS Innovations (Nasdaq: SSII) successfully completed the first telesurgery using its SSi Mantra Tele Surgeon Console (TSC), enabling remote operations from any connected location.
SS Innovations Reports Third Quarter 2025 Financial Results
Quarterly Revenue Increased 192.5% Year over Year to $12.8 Million Driven by Higher SSi Mantra 3 Unit Sales Fort Lauderdale, FL, October 28, 2025 – PRISM MediaWire (Press Release Service – Press Release Distribution) – SS Innovations International, Inc.
SS Innovations Provides U.S. Regulatory Update for the SSi Mantra Surgical Robotic System
Company successfully completed a human factors validation study at Johns Hopkins Hospital Anticipates submitting a 510(k) premarket notification to the FDA in the fourth quarter of 2025 Fort Lauderdale, FL, October 2, 2025 – PRISM MediaWire (Press Release Service – Press Release Distribution) – SS Innovations International, Inc.
